Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

Related Citations for PubMed (Select 23696020)

1.

High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma.

Liu G, Huang X, Cui X, Zhang J, Wei L, Ni R, Lu C.

Med Oncol. 2013;30(3):537. doi: 10.1007/s12032-013-0537-4. Epub 2013 May 22.

PMID:
23696020
2.

Expression of SGTA correlates with prognosis and tumor cell proliferation in human hepatocellular carcinoma.

Lu C, Liu G, Cui X, Zhang J, Wei L, Wang Y, Yang X, Liu Y, Cong X, Lv L, Ni R, Huang X.

Pathol Oncol Res. 2014 Jan;20(1):51-60. doi: 10.1007/s12253-013-9657-6. Epub 2013 Jul 10.

PMID:
23839012
3.

Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.

Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, Yao Y, Liu Q.

Mol Cancer. 2014 May 17;13:110. doi: 10.1186/1476-4598-13-110.

4.

Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.

Chen HW, Huang XD, Li HC, He S, Ni RZ, Chen CH, Peng C, Wu G, Wang GH, Wang YY, Zhao YH, Zhang YX, Shen AG, Wang HM.

Mol Carcinog. 2013 Aug;52(8):647-59. doi: 10.1002/mc.21904. Epub 2012 Apr 4.

PMID:
22488567
5.

Expression and prognostic role of SKIP in human breast carcinoma.

Liu X, Ni Q, Xu J, Sheng C, Wang Q, Chen J, Yang S, Wang H.

J Mol Histol. 2014 Apr;45(2):169-80. doi: 10.1007/s10735-013-9546-z. Epub 2013 Oct 23.

PMID:
24150787
6.

SKIP expression is correlated with clinical prognosis in patients with bladder cancer.

Wang L, Zhang M, Wu Y, Cheng C, Huang Y, Shi Z, Huang H.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1695-701. eCollection 2014.

7.

High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.

Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M.

Pathol Oncol Res. 2013 Jan;19(1):79-88. doi: 10.1007/s12253-012-9560-6. Epub 2012 Sep 12.

PMID:
22965687
8.

LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.

Wang H, Li W, Jin X, Cui S, Zhao L.

Eur J Cancer. 2013 Mar;49(4):974-83. doi: 10.1016/j.ejca.2012.09.032. Epub 2012 Oct 18.

PMID:
23084841
9.

Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.

Huang X, Liu F, Zhu C, Cai J, Wang H, Wang X, He S, Liu C, Yao L, Ding Z, Zhang Y, Zhang T.

Dig Dis Sci. 2014 Apr;59(4):795-806. doi: 10.1007/s10620-013-2969-2. Epub 2013 Dec 25.

10.

Chaperonin containing TCP1, subunit 8 (CCT8) is upregulated in hepatocellular carcinoma and promotes HCC proliferation.

Huang X, Wang X, Cheng C, Cai J, He S, Wang H, Liu F, Zhu C, Ding Z, Huang X, Zhang T, Zhang Y.

APMIS. 2014 Nov;122(11):1070-9. doi: 10.1111/apm.12258. Epub 2014 May 26.

PMID:
24862099
11.

Clinical and biological significance of never in mitosis gene A-related kinase 6 (NEK6) expression in hepatic cell cancer.

Cao X, Xia Y, Yang J, Jiang J, Chen L, Ni R, Li L, Gu Z.

Pathol Oncol Res. 2012 Apr;18(2):201-7. doi: 10.1007/s12253-011-9429-0. Epub 2011 Jul 5.

PMID:
21725899
12.

Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.

Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y, Zhang L, Li P, Cui X, Chen L, He S, Shen A.

Exp Mol Pathol. 2009 Dec;87(3):167-72. doi: 10.1016/j.yexmp.2009.07.011. Epub 2009 Aug 15.

PMID:
19686732
13.

Upregulated expression of CAP1 is associated with tumor migration and metastasis in hepatocellular carcinoma.

Liu Y, Cui X, Hu B, Lu C, Huang X, Cai J, He S, Lv L, Cong X, Liu G, Zhang Y, Ni R.

Pathol Res Pract. 2014 Mar;210(3):169-75. doi: 10.1016/j.prp.2013.11.011. Epub 2013 Dec 5.

PMID:
24359721
14.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

15.

Characterization of bridging integrator 1 (BIN1) as a potential tumor suppressor and prognostic marker in hepatocellular carcinoma.

Pan K, Liang XT, Zhang HK, Zhao JJ, Wang DD, Li JJ, Lian Q, Chang AE, Li Q, Xia JC.

Mol Med. 2012 May 9;18:507-18. doi: 10.2119/molmed.2011.00319.

16.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K.

Tumour Biol. 2012 Dec;33(6):2125-34. doi: 10.1007/s13277-012-0472-6. Epub 2012 Aug 4.

PMID:
22864671
17.
18.

Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).

Zhao Y, Tang Q, Ni R, Huang X, Wang Y, Lu C, Shen A, Wang Y, Li C, Yuan Q, Chen H, Cheng C, He S.

Hum Pathol. 2013 Mar;44(3):365-73. doi: 10.1016/j.humpath.2012.03.030. Epub 2012 Sep 17.

PMID:
22995332
19.

Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.

Wang B, Tang J, Liao D, Wang G, Zhang M, Sang Y, Cao J, Wu Y, Zhang R, Li S, Ding W, Zhang G, Kang T.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S684-92. doi: 10.1245/s10434-013-3171-7. Epub 2013 Aug 14.

PMID:
23943028
20.

CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.

Liu F, Lv H, Jia X, Liu G, Li T, Xu Z, Li J.

J Surg Oncol. 2014 Aug;110(2):151-5. doi: 10.1002/jso.23598. Epub 2014 Mar 14.

PMID:
24634224
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk